MTARC1 and Cirrhosis: The precise method by which MARC1 may influence liver damage and cirrhosis remains uncertain, but it is known that MARC1 encodes a molybdenum-containing nitric oxide synthase that reduces the physiological substrate N(omega)-hydroxy-L-arginine and activates it.